TABLE 1.
Meningococcal strains used in serum bactericidal assays at the two laboratories
| Strain type | Laboratory | Strain | Typing | Epidemic clone | Country origin and yr |
|---|---|---|---|---|---|
| Homologous or PorA related | GSK Biologicals | M97250687a | B:4:P1.19,15:L3 | ST-32 complex | United Kingdom, 1997 |
| NZ124/98a | B:4:P1.7-2,4:L3 | ST-44 complex | New Zealand, 1998 | ||
| HPA | M01 240101b,c | B:NT:P1.19-1,15-11 | ST-269 complex | United Kingdom, 2001 | |
| M01 240149a,c | B:4:P1.7-2,4 | ST-44 complex | United Kingdom, 2001 | ||
| Heterologous | GSK Biologicals | H44/76 | B:15:P1.7,16:L3 | ST-32 complex | Norway, 1976 |
| BZ10 | B:2b:P1.2:L3 | ST-8 complex | Netherlands, 1967 | ||
| B16B6 | B:2a:P1.2:L2 | ST-11 complex | United States, mid-1960s | ||
| HPA | H44/76 | B:15:P1.7,16:L3 | ST-32 complex | Norway, 1976 | |
| M01 240355c | B:1:P1.22,14 | ST-213 complex | United Kingdom, 2001 | ||
| M01 240185c | B:2a:P1.15-1,10-8 | ST-11 complex | United Kingdom, 2001 | ||
| M01 240013c | B:NT:P1.22,9 | ST-269 complex | United Kingdom, 2001 |
a
Strain has PorA identical to that of the corresponding vaccine strain and is from the same MLST complex.
b
This strain has PorA similar but not identical to that of the corresponding vaccine strain and is from a different MLST complex.
c
LOS typing not available.